Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
Public ClinicalTrials.gov record NCT07001748. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Protocol EA2234: A Randomized Phase II/III Trial of Intraperitoneal Paclitaxel Plus Systemic Treatment vs Systemic Treatment Alone in Gastric Carcinomatosis - STOPGAP II
Study identification
- NCT ID
- NCT07001748
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Lead sponsor
- ECOG-ACRIN Cancer Research Group
- Network
- Enrollment
- 148 participants
Conditions and interventions
Conditions
Interventions
- Biospecimen Collection Procedure
- Computed Tomography Procedure
- Diagnostic Laparoscopy Procedure
- Intraperitoneal Paclitaxel Drug
- Intraperitoneal Port Placement Procedure
- Magnetic Resonance Imaging Procedure
- Standard of Care Chemotherapy Drug
Procedure · Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 18, 2025
- Primary completion
- May 29, 2030
- Completion
- May 29, 2030
- Last update posted
- May 4, 2026
2025 – 2030
United States locations
- U.S. sites
- 10
- U.S. states
- 5
- U.S. cities
- 7
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UC Irvine Health/Chao Family Comprehensive Cancer Center | Irvine | California | 92612 | Recruiting |
| UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care | Orange | California | 92868 | Recruiting |
| Schulze Family Foundation Cancer Clinic - Bonita Health Center | Bonita Springs | Florida | 34135 | Not yet recruiting |
| Lee Memorial Health System | Fort Myers | Florida | 33901 | Not yet recruiting |
| Regional Cancer Center-Lee Memorial Health System | Fort Myers | Florida | 33905 | Not yet recruiting |
| University of Kentucky/Markey Cancer Center | Lexington | Kentucky | 40536 | Recruiting |
| UPMC Hillman Cancer Center | Pittsburgh | Pennsylvania | 15232 | Not yet recruiting |
| UPMC-Passavant Hospital | Pittsburgh | Pennsylvania | 15237 | Not yet recruiting |
| University of Wisconsin Carbone Cancer Center - Eastpark Medical Center | Madison | Wisconsin | 53718 | Not yet recruiting |
| University of Wisconsin Carbone Cancer Center - University Hospital | Madison | Wisconsin | 53792 | Not yet recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07001748, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 4, 2026 · Synced May 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07001748 live on ClinicalTrials.gov.